SANSURE BIOTECH INC.
Established in 2008, as a complete molecular diagnostic solutions developer, manufacturer, and provider, Sansure Biotech, Inc. has nearly 10-years experience specializing in molecular diagnostic reagents, instruments and medical service which focuses on clinical diagnosis, public health, research application and food safety.
Under the leadership of Dr. Dai, Sansure has developed a complete range of molecular diagnostic products with an international standard of excellence in infectious diagnosis, early screening of cancer, prenatal and postnatal diagnosis, etc. Sansure has won the second prize of National Science and Technology Progress Award, China Patent Award of Excellence, China Invention and Entrepreneurship Award and other national major innovation awards for its outstanding contributions in Chinese molecular diagnostic market.
Sansure devotes to turning the expensive molecular diagnostic to affordable and accessible medical service to everyone needed. With such mission in mind, Sansure’s products have been widely used in more than 1000 hospitals including the class A hospital in China and exported to more than 30 countries including Central and Eastern Europe, Africa, Southeast Asia, etc.